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PCardiac Imaging
rognostic Value of Lung Sestamibi
ptake in Myocardial Perfusion Imaging of Patients
ith Known or Suspected Coronary Artery Disease
illiam D. Leslie, MD, MSC,* Shawn A. Tully, MD,* Marina S. Yogendran, MSC,†
inda M. Ward, RT(NM),* Khaled A. Nour, MD,* Colleen J. Metge, PHD†
innipeg, Canada
OBJECTIVES We sought to determine whether lung uptake of technetium-99m (99mTc)-based myocardial
perfusion tracers predicts cardiac events.
BACKGROUND Increased lung uptake of thallium-201 during myocardial perfusion scintigraphy can predict
important clinical outcomes. It is unclear whether lung uptake of 99mTc-based myocardial
perfusion tracers can be used in a similar way.
METHODS Stress lung-to-heart ratio (sLHR) was determined in 718 patients undergoing 99mTc-
sestamibi single-photon emission computed tomographic stress imaging. The primary
outcome was acute myocardial infarction or death.
RESULTS During a mean follow-up of 5.6 years, a primary end point occurred in 114 patients (16%).
The sLHR was significantly greater in those with an adverse outcome (p  0.00001). The
likelihood of an adverse outcome increased by a factor of 1.5 (95% confidence interval 1.2 to
1.7) for each standard deviation increase in sLHR after adjustment for all other variables. The
sLHR provided a small but significant improvement in risk stratification when added to
clinical, stress test, perfusion, and left ventricular volume information (global chi-square 168.6
vs. 150.7, p  0.00001).
CONCLUSIONS Stress LHR is an adjunctive prognostic measure in patients with known or suspected coronary
artery disease. (J Am Coll Cardiol 2005;45:1676–82) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.059Cardiology Foundation
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the assessment of myocardial perfusion using radioactive
racers has consistently been shown to provide important
rognostic information in patients with known or suspected
oronary artery disease (CAD). Increased lung uptake of
hallium-201 (201Tl) after a stress procedure has been
trongly associated with severe CAD and cardiac events
1,2). It is currently unclear whether the assessment of lung
ptake on technetium-99m (99mTc)-based perfusion scin-
igraphy provides clinically useful ancillary information or
ot. Although some groups have shown that 99mTc-
estamibi lung uptake correlates with left ventricular (LV)
ysfunction and CAD severity (3–5), this index has not yet
een shown to predict important cardiac events.
ETHODS
tudy population. Between January 1994 and April 1999,
onsecutive patients who underwent stress and rest 99mTc-
estamibi single-photon emission computed tomographic
SPECT) myocardial perfusion imaging on the same imag-
ng system (Elscint 409; Haifa, Israel) were considered for
nclusion in the study cohort (n 1,027). The study cohort,
From the *Department of Nuclear Medicine, St. Boniface General Hospital,
innipeg; and †Manitoba Centre for Health Policy, Winnipeg, Canada. This study
as supported by grants from the Canadian Institute for Health Research and the Rx
D Foundation.c
Manuscript received June 24, 2004; revised manuscript received February 3, 2005,
ccepted February 8, 2005.tress procedures, and image processing used in our labora-
ory have been previously described (6). Exclusion criteria
ncluded planar imaging or imaging not completed on the
esignated camera (n  36), corrupted (n  102) or poor
uality image data (n 2), nonstandard stress procedures (n
4), or the inability to link patient data to the Manitoba
opulation Health Research Data Repository (n  140).
or patients undergoing more than one scan during the
tudy period, only the first scan was included in the analysis
n  25). The study protocol was approved by the local
esearch Ethics Board and provincial Health Information
rivacy Committee.
tress protocols and imaging. A two-day protocol utiliz-
ng treadmill exercise is the preferred procedure in our
aboratory. Whenever possible, beta-blockers and calcium
hannel antagonists are withheld for 24 to 48 h before the
tress procedure, and nitrates are avoided for at least 6 h.
ymptom-limited treadmill exercise was performed with
racer injection at peak exercise. Individuals unable to
chieve a satisfactory exercise workload underwent pharma-
ologic stress with dipyridamole. Supine, nongated SPECT
maging commenced 30 to 60 min after stress and 45 to 75
in after the resting injection.
cintigraphic interpretation. Initial visual interpretation
f the scan data was performed without image quantifica-
ion using two variables: a normal scan (normal or equivo-
al) versus abnormal scan (abnormal with fixed or reversible
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May 17, 2005:1676–82 Sestamibi Lung Uptakeefects); and no reversibility (normal, equivocal, or abnor-
al with fixed defects) versus reversibility (abnormal with
ully reversible or partially reversible defects). Image data
ere subsequently reprocessed using commercial software
AutoSPECT and QPS AutoQUANT, Cedar Sinai Med-
cal Center and ADAC Laboratories, Milpitas, California).
eft ventricular contours were checked visually and manu-
lly adjusted if the computer-generated automatic contours
ere found to be incorrect. This software provides quanti-
ative defect scores for the summed stress score (SSS),
ummed rest score (SRS), and summed difference score
SDS) based on a 20-segment model (7,8). We have
reviously shown close agreement between the visual and
utomated quantitative assessment in terms of diagnosis and
rognosis (6,9). Visual interpretation and the quantitative
nalysis were performed without knowledge of patient
utcomes.
Lung uptake of 99mTc-sestamibi was calculated as the
ung-to-heart ratio (LHR), using a validated automated
echnique (3). The LHR was measured on stress (sLHR)
nd rest projection data (rLHR), and the difference (dLHR)
as derived by subtraction. Mean sLHR was identical for
xercise only and pharmacologic stress, and these groups
ere combined in subsequent analysis. Excellent interob-
erver agreement in LHR measurements was confirmed in
0 blindly reprocessed cases (sLHR: R  0.97, p 
.00001, mean difference 0.01; and rLHR: R  0.95, p 
.00001, mean difference 0.01).
An automated calculation of ungated LV volumes after
tress and at rest was obtained (10). Transient ischemic
ilation was derived from the endocardial volumes as the
atio of LV volume at stress divided by the volume at rest.
utcomes assessment. Cohort follow-up was performed
hrough the Manitoba Population Health Research Data
epository, which links computerized data bases of physi-
ian services and hospitalizations for all residents of the
rovince of Manitoba (11). The primary outcome was death
from Vital Statistics) or acute myocardial infarction (AMI;
ospital diagnosis ICD-9-CM 410.xx). Clinical and stress
ariables were primarily obtained from chart review. The
Abbreviations and Acronyms
AMI  acute myocardial infarction
CAD  coronary artery disease
dLHR  difference in lung-to-heart ratios
LHR  lung-to-heart ratio
LV  left ventricle
rLHR  rest lung-to-heart ratio
SDS  summed difference score
sLHR  stress lung-to-heart ratio
SPECT single-photon emission computed tomography
SRS  summed rest score
SSS  summed stress score
201Tl  thallium-201
99mTc  technetium-99mepository was used to identify diabetes or previous AMI. btatistical analysis. Statistical analysis was performed with
commercial software package (Statistica Version 6.1,
tatSoft Inc., Tulsa, Oklahoma). Continuous variables are
eported as the mean value  SD, and p  0.05 is
onsidered to represent a statistically significant difference.
roup comparisons were performed using analysis of vari-
nce (ANOVA) or chi-square testing. Kaplan-Meier sur-
ival curves were compared using Gehan’s Wilcoxon test.
eceiver operating characteristic (ROC) curves were gen-
rated with SPSS version 11.0 (SPSS Inc., Chicago, Illi-
ois). Multivariate survival analysis used Cox proportional
azards modeling. One model was developed for the com-
lete study cohort using clinical variables, stress modality,
erfusion, LV volume, and LHR measurements. A second
odel was developed for those undergoing treadmill exer-
ise only and also included exertional chest pain, electrocar-
iographic ischemia, peak workload, peak heart rate, peak
ystolic blood pressure, and peak double product. An initial
partial) regression was limited to competing variables from
ithin each of the clinical, exercise, volume, and lung
ptake variable subgroups in order to select the final
combined) regression variables. If significant collinearity
as identified (R  0.5), only the factor with the strongest
ssociation was entered.
ESULTS
atient characteristics. Of the 718 patients included in the
nalysis, 380 (53%) were males, 186 (26%) had a history of
I, 112 (16%) had undergone a previous coronary artery
ypass graft surgery or coronary angioplasty, 90 (13%) were
iabetic, and 556 (77%) had treadmill exercise as the only
tress method.
ung uptake measurements. Overall, mean sLHR (0.32
0.06) was slightly greater than the rLHR (0.31  0.06; p
0.001 by paired comparison). Lung uptake measurements
howed significant differences according to the severity of
erfusion abnormality, as reflected in the SSS, with greater
tress and rLHR in association with more extensive perfu-
ion abnormalities (Table 1).
urvival analysis. During a mean follow-up of 5.6  1.1
ears, 114 patients (16%) experienced a primary event.
here were 81 deaths and 62 AMIs, including 29 patients
ecorded as having AMI followed by death.
Mean sLHR was higher in individuals who had an
dverse outcome, as compared with those who remained
vent-free (0.36 0.08 vs. 0.31 0.06, p 0.00001). This
as even identified in the subgroup with normal SSS (0.33
0.06 vs. 0.30  0.05, p  0.002). Two-way ANOVA
onfirmed higher sLHR in relation to an adverse clinical
utcome (p  0.00001), independent of the SSS category.
ndividuals with an adverse outcome also had a higher mean
LHR (0.34  0.07 vs. 0.31  0.06, p  0.00001) and
LHR (0.016  0.057 vs. 0.004  0.050, p  0.02).
The ROC analysis confirmed a significant associationetween adverse outcomes over the range of sLHR mea-
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Sestamibi Lung Uptake May 17, 2005:1676–82urements (Fig. 1). The area under the curve was 0.65 for
LHR (95% confidence interval [CI] 0.59 to 0.71, p 
.0001), 0.62 for rLHR (95% CI 0.57 to 0.69, p 0.0001),
nd 0.56 for dLHR (95% CI 0.51 to 0.62, p  0.04). For
omparison, the area under the curve was 0.67 for SSS (95%
I 0.61 to 0.73), 0.67 for SRS (95% CI 0.61 to 0.73), and
.63 for SDS (95% CI 0.57 to 0.68). The area under the
urve for sLHR was similar for the individual end points of
eath (0.65, 95% CI 0.58 to 0.72, p  0.001) and AMI
0.67, 95% CI 0.60 to 0.74, p  0.001). Subgroup analysis
or individuals with a normal SSS gave an area under the
urve for sLHR (0.64, 95% CI 0.52 to 0.75, p  0.01),
imilar to the overall group. Event-free survivals according
o sLHR tertiles (Fig. 2) were significantly different (p 
.00001).
Table 2 summarizes the univariate analysis for the com-
lete study cohort. Multivariate analysis identified six vari-
bles as independent predictors of death or AMI (Table 3).
hese were older age (p  0.00001), previous MI (p 
.001), diabetes (p  0.00001), pharmacologic stress (p 
.00001), stress LV volume (p 0.00001), and sLHR (p
.00001). The relative hazard increased by a factor of 1.5
95% CI 1.2 to 1.8) for each standard deviation (SD)
ncrease in sLHR after adjustment for all other variables.
A secondary analysis was performed in those 556 patients
ndergoing treadmill exercise only (Table 4). Multivariate
able 1. Relationship Between Lung Uptake and Summed Stress
Overall
(n  718)
Normal
(n  367)
LHR† 0.32  0.06 0.30  0.0
LHR† 0.31  0.06 0.30  0.0
LHR‡ 0.006  0.051 0.003  0.0
value: sLHR vs. rLHR 0.001 0.15
The summed stress score (SSS) was categorized as normal (3) or mildly (4 to 8
ategories: †p  0.00001, ‡p  0.04. Data are presented as the mean value  SD.
dLHR, rLHR, and sLHR  difference in, rest, and stress lung-to-heart ratio, res
igure 1. Receiver operating characteristic analysis for predicting death or
cute myocardial infarction from stress lung-to-heart ratio (LHR) (solid
ine) or summed stress score (SSS) (dotted line).
F
tnalysis identified five variables as independent predictors of
n adverse outcome (Table 5). These were male gender (p
.01), diabetes (p  0.006), peak workload (p  0.00006),
tress LV volume (p  0.0001), and sLHR (p  0.003).
he relative hazard increased by a factor of 1.4 (95% CI 1.1
o 1.8) for each SD increase in sLHR after adjustment for
ll other variables.
ncremental contribution. Figure 3 shows the incremental
mprovement in the global chi-square for predicting death
r AMI, using variables that were found to be independent
redictors of outcome. As no perfusion variables were in
hese final models, we also included SSS. There was a
tatistically significant increase when the model using clin-
cal variables alone (global chi-square 92.1) was augmented
ith variables related to the stress test (122.0, p 0.00001),
erfusion data (127.0, p  0.08), left volume (150.7, p 
.00001), and lung uptake (168.6, p  0.00001). In the
xercise-only subgroup, the inclusion of sLHR also pro-
ided a small but significant incremental improvement in
isk stratification when added to clinical, stress test, perfu-
ion, and volume information (global chi-square 85.5 vs.
7.1, p  0.004).
ISCUSSION
his study provides direct evidence that 99mTc-sestamibi
LHR predicts subsequent AMI or death. Furthermore, this
re* Category
Mild
(n  136)
Moderate
(n  78)
Severe
(n  137)
0.31  0.05 0.34  0.08 0.36  0.07
0.31  0.05 0.32  0.07 0.35  0.06
0.000  0.048 0.017  0.065 0.012  0.053
0.2 0.02 0.008
erately (9 to 13), and severely abnormal (13). Analysis of variance between SSS
ely.Sco
5
5
46
), modigure 2. Kaplan-Meier plots of event-free survival according stress lung-
o-heart ratio (LHR) tertile.
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May 17, 2005:1676–82 Sestamibi Lung Uptakenformation appears to be incremental when combined with
ther clinical and test-related information.
ung uptake measurements. The LHR measurements
ncreased in association with worsening stress perfusion
bnormalities. Lung uptake of 201Tl after stress has been
orrelated with a rise in pulmonary capillary wedge pressure
ue to exercise-induced LV dysfunction (12). Increased
esting pulmonary 201Tl uptake has also been correlated
ith LV dysfunction, the extent of CAD, and resting
erfusion abnormalities (13,14). Hurwitz et al. (15) re-
Table 2. Baseline Characteristics, Stress Proced
Occurrence of a Primary Event for All Patient
Total
(n  718)
Clinical variables
Age (yrs) 60  11
Gender (male) 380 (53%)
Previous AMI 186 (26%)
Previous revascularization 112 (16%)
Diabetes 90 (13%)
Stress test modality
Exercise 556 (77%)
Dipyridimole 162 (23%)
Perfusion
Visually abnormal 330 (46%)
Visual reversibility 281 (39%)
SSS 7  9
SRS 3  6
SDS 4  5
LV volume
Stress (ml) 79  55
Rest (ml) 76  52
TID 1.03  0.14
Lung uptake
sLHR 0.32  0.06
rLHR 0.31  0.06
dLHR 0.006  0.051
Data are presented as the mean value  SD or number (%)
AMI  acute myocardial infarction; LV  left ventricular
 summed stress score; TID  transient ischemic dilation;
Table 3. Stepwise Regression Analysis for the
Initial
HR* (95%
Clinical variables
Age (yrs) 1.7 (1.4–
Gender (male) 1.7 (1.1–
Previous AMI 2.3 (1.6–
Diabetes 2.9 (1.9–
Stress test
Pharmacologic stress (vs. exercise) 4.0 (2.7–
Perfusion
SSS 1.6 (1.4–
LV volume
Stress 1.6 (0.6–
TID 1.2 (1.0–
Lung uptake
sLHR 1.8 (1.5–
dLHR 0.9 (0.8–*Hazard ratios (HR) for continuous variables expressed per SD.
CI  confidence interval; HR  hazard ratio; other abbreviatioorted that lung sestamibi was elevated in 15% to 17% of
xercise studies using planar images obtained 4 min after
njection, versus 9% to 10% on delayed acquisitions. In-
reased values were related to ischemic and fixed perfusion
efects, LV dilation, LV dysfunction, and coronary steno-
es. This suggests that the mechanism for enhanced 99mTc-
estamibi lung uptake is similar to lung uptake of 201Tl. The
isadvantage of early imaging is that it negates much of the
onvenience and scheduling efficiency of sestamibi over
hallium. A direct comparison of the relative prognostic
and Scan Findings in Relation to the
Events
(n  114)
No Events
(n  604) p Value
66  11 59  11 0.00001
78 (68%) 302 (50%) 0.0003
56 (49%) 130 (22%) 0.00001
22 (19%) 90 (15%) 0.2
33 (29%) 57 (9%) 0.00001
59 (52%) 497 (82%) 0.00001
55 (48%) 107 (18%) 0.00001
83 (73%) 247 (41%) 0.00001
65 (57%) 216 (36%) 0.00002
12  11 6  8 0.00001
6  8 2  5 0.00001
5  5 3  4 0.00007
120  90 71  41 0.00001
113  86 69  39 0.00001
1.06  0.17 1.02  0.13 0.01
0.36  0.08 0.31  0.06 0.00001
0.34  0.07 0.31  0.06 0.00001
.016  0.057 0.004  0.050 0.02
es.
 summed difference score; SRS  summed rest score; SSS
abbreviations as in Table 1
rrence of a Primary Event for All Patients
ial Models Final Combined Model
p Value HR* (95% CI) p Value
0.0001 1.7 (1.4–2.1) 0.00001
0.008
0.00002 1.9 (1.3–2.8) 0.001
0.00001 2.6 (1.7–3.9) 0.00001
0.00001 2.5 (1.7–3.7) 0.00001
0.00001
0.00001 1.4 (1.2–1.5) 0.00001
0.067
0.00001 1.5 (1.2–1.7) 0.00001
0.2ure,
s
0
of casOccu
Part
CI)
2.1)
2.6)
3.3)
4.4)
5.8)
1.9)
4.2)
1.5)
2.1)
1.1)ns as in Tables 1 and 2.
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Sestamibi Lung Uptake May 17, 2005:1676–82able 4. Baseline Characteristics, Exercise Results, and Scan Findings in Relation to the Occurrence of a Primary Event for Patients
ho Performed Treadmill Exercise Stress Only
Total
(n  556)
Events
(n  59)
No Events
(n  497) p Value
linical variables
Age (yrs) 59  11 61  11 58  11 0.02
Gender (male) 303 (54%) 42 (71%) 261 (53%) 0.006
Previous AMI 136 (24%) 27 (46%) 109 (22%) 0.00006
Previous revascularization 83 (15%) 13 (22%) 70 (14%) 0.11
Diabetes 51 (9%) 13 (22%) 38 (8%) 0.0003
xercise
Chest pain 114 (21%) 22 (37%) 92 (19%) 0.0007
Ischemic ECG 115 (21%) 12 (20%) 103 (21%) 0.2
Resting heart rate (beats/min) 72  14 74  15 72  14 0.2
Resting systolic blood pressure (mm Hg) 137  22 135  20 137  22 0.2
Peak heart rate (beats/min) 131  21 122  19 133  21 0.00008
Peak systolic blood pressure (mm Hg) 171  27 161  30 172  26 0.003
Peak double product (1,000) 22.6  5.5 19.7  5.5 22.9  5.4 0.00002
Peak workload (METs) 8.6  2.7 7.2  2.7 8.7  2.7 0.00009
erfusion
Visually abnormal 229 (41%) 39 (66%) 190 (38%) 0.00004
Visual reversibility 193 (35%) 29 (49%) 164 (33%) 0.01
SSS 6  9 11  12 6  8 0.00001
SRS 3  6 6  9 2  5 0.00001
SDS 3  4 5  5 3  4 0.001
V volume
Stress (ml) 76  50 122  98 70  38 0.00001
Rest (ml) 73  45 116  85 68  35 0.00001
TID 1.02  0.13 1.04  0.13 1.02  0.12 0.18
ung uptake
sLHR 0.32  0.06 0.36  0.09 0.31  0.06 0.00001
rLHR 0.31  0.06 0.34  0.07 0.31  0.06 0.00001
dLHR 0.010  0.051 0.024  0.062 0.008  0.049 0.02ata are presented as the mean value  SD or number (%) of patients.
ECG  electrocardiogram; METs  metabolic equivalents; other abbreviations as in Tables 1 and 2.Table 5. Stepwise Regression Analysis for the Occurrence of a Primary Event for Patients Who
Performed Treadmill Exercise Stress Only
Initial Partial Models Final Combined Model
HR* (95% CI) p Value HR* (95% CI) p Value
Clinical variables
Age (yrs) 1.2 (0.9–1.7) 0.11
Gender (male) 1.9 (1.1–3.3) 0.04 2.2 (1.2–4.0) 0.01
Previous AMI 2.1 (1.2–3.6) 0.007
Diabetes 2.5 (1.4–4.7) 0.004 2.5 (1.3–4.7) 0.006
Exercise
Chest pain 1.8 (1.0–3.1) 0.03
Peak double product 0.7 (0.5–0.9) 0.003
Peak workload (METs) 0.6 (0.4–0.9) 0.006 0.5 (0.3–0.7) 0.00006
Perfusion
SSS 1.6 (1.3–2.0) 0.00001
LV volume
Stress (ml) 1.7 (1.6–1.9) 0.00001 1.4 (1.2–1.7) 0.0001
TID 1.0 (0.8–1.4) 0.2
Lung uptake
sLHR 1.9 (1.5–2.5) 0.00001 1.4 (1.1–1.8) 0.003
dLHR 0.9 (0.7–1.1) 0.2*Hazard ratios (HR) for continuous variables expressed per SD.
Abbreviations as in Tables 1 to 4.
v
i
S
h
t
u
s
c
O
m
i
t
e
u
a
w
S
f
o
s
C
I
m
v
m
o
s
n
u
S
e
s
e
s
e
t
m
t
o
e
p
s
j
t
d
a
R
m
m
C
p
C
d
fi
s
t
e
A
W
M
c
m
T
a
R
D
F
l
m
(
1681JACC Vol. 45, No. 10, 2005 Leslie et al.
May 17, 2005:1676–82 Sestamibi Lung Uptakealue of early lung uptake characterization and delayed
maging is needed.
urvival analysis. The sLHR and rLHR were significantly
igher in individuals who experienced AMI or death than in
hose individuals who remained event-free. The degree of
nivariate risk stratification, as determined by ROC analy-
is, was similar for sLHR, rLHR, and SSS. In contrast, a
hange in lung uptake provided minimal risk stratification.
ther reports have emphasized that prognostic variables
ay differ in terms of predicting AMI and death (16), but
n our cohort, sLHR provided similar risk stratification for
hese individual end points.
The variables independently associated with a lower
vent-free survival were older age, previous MI, diabetes,
se of pharmacologic stress, larger stress LV chamber size,
nd sLHR. In the exercise only subgroup, peak workload
igure 3. Incremental contribution of clinical, stress procedure, perfusion,
eft ventricular volume, and lung uptake variables on prediction of acute
yocardial infarction (MI) or death (see text for details). (A) All patients.
B) Treadmill exercise patients only.as also predictive. Surprisingly, perfusion, as assessed by
CSS, was no longer a significant predictor after adjustment
or all other information. This finding is consistent with the
bservation that increased lung thallium uptake was the
trongest predictor of a cardiac event (relative risk 3.5, 95%
I 2.2 to 5.4) (1).
ncremental contribution. The sLHR was additive to a
odel containing clinical, stress, perfusion, and LV
olume information. Although the incremental improve-
ent was modest, LHR measurement is available with-
ut any additional cost. Because no attempt was made to
tandardize the time between tracer injection and scan-
ing, there was no interference with optimal camera
tilization.
tudy limitations and clinical implications. Although
levated lung uptake of sestamibi (highest tertile) is a
trong univariate predictor of death or AMI (annualized
vent rate 4.8% per year), uptake in the lowest tertile is
till associated with an intermediate risk (annualized
vent rate 1.6% per year), and other clinical and labora-
ory information must be considered in clinical decision-
aking. A limitation of our study is the lack of informa-
ion on LV performance. Prognostic information can be
btained from the gated SPECT measurement of LV
jection fraction when combined with an assessment of
erfusion (17). Our use of ungated LV volume as a
urrogate for LV ejection fraction is not ideal but can be
ustified from the strong inverse relationship between
hese two parameters (18). Reliance on administrative
ata for assessing end points could also be questioned,
lthough the Manitoba Population Health Research Data
epository has been used to validate prediction rules of
ortality after AMI, and there is unlikely to be disagree-
ent over the occurrence of death (19).
onclusions. The sLHR appears to be another adjunctive
rognostic measure in patients with known or suspected
AD. Before this measurement is routinely used for clinical
ecision-making, further studies are required to confirm our
nding that lung uptake measurements can enhance risk
tratification over conventional prognostic variables, and
hese studies should include a direct measurement of LV
jection fraction.
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